SANGAMO THERAPEUTICS, INC. (SGMOQ) Shareholders’ equity 2016–2025
SANGAMO THERAPEUTICS, INC. (SGMOQ) shareholders’ equity at each fiscal year-end, per SEC filings.
-$14.3MFY2025 · since FY2016: $136.2M → -$14.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.3M | -162.7% |
| FY2024 | $22.8M | -72.5% |
| FY2023 | $82.9M | -71.9% |
| FY2022 | $295.0M | -21.4% |
| FY2021 | $375.3M | -24.7% |
| FY2020 | $498.2M | +15.2% |
| FY2019 | $432.6M | +18.0% |
| FY2018 | $366.5M | +95.1% |
| FY2017 | $187.9M | +38.0% |
| FY2016 | $136.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice